Zalewska-Adamiec Malgorzata, Kuzma Lukasz, Dobrzycki Slawomir, Bachorzewska-Gajewska Hanna
Department of Invasive Cardiology, Medical University of Bialystok, Białystok, Poland.
Department of Clinical Medicine, Medical University of Bialystok, Białystok, Poland.
J Interv Cardiol. 2020 Apr 24;2020:4340930. doi: 10.1155/2020/4340930. eCollection 2020.
The prognosis of Takotsubo syndrome (TTS) is comparable to that of the non-ST-elevation myocardial infarction (NSTEMI). The GRACE scale is used to assess the risk of premature and long-term mortality in patients with NSTEMI in order to select the most favorable treatment strategy.
101 patients with TTS hospitalized in four centers of invasive cardiology in Podlaskie Voivodeship during the period 2008-2012 were included in the study. The patients were divided into two groups: I-52 patients (GRACE ≤ 140 points) and II-49 patients (GRACE > 140 points).
The mean GRACE score in the study group was 138.66. The in-hospital stay of Takotsubo in the patients with higher GRACE scores was associated with higher incidence of pneumonia (36.7% vs 7.69%, =0.0004), rhythm abnormalities (17.3% vs 3.85%, =0.026), and serious complications (cardiogenic shock, pulmonary edema, and sudden cardiac arrest) (30.6% vs 5.77%, =0.001). The mean observation period was 7.2 years. A significantly higher risk of 6-month (18.37% vs 3.85%, =0.019), 1-year (22.45 vs 3.85%, =0.005), 3-year (40.82 vs 3.85%, < 0.0001), 5-year (42.86% vs 3.85%, < 0.0001), and 7-year mortalities (53.06% vs 9.62%, < 0.0001) was observed in the group of patients with a GRACE score ≥140. At multivariate analysis including low BMI, low eGFR, and a higher GRACE score, all these factors were independent predictor of death (=0.042; =0.010; =0.041). The ROC curve presents the discriminatory scores of the GRACE scale for the follow-up prognostication. The area under ROC curve (AUC) for the GRACE scale was 0.805 (95% CI: 0.718-0.892, < 0.0001), with a cut-off value of 153 points, sensitivity of 74%, and specificity of 77% for TTS.
The GRACE scale is highly valuable for the prognostication of death risk in patients with TTS in the early and long-term observation.
应激性心肌病(TTS)的预后与非ST段抬高型心肌梗死(NSTEMI)相当。GRACE评分用于评估NSTEMI患者过早死亡和长期死亡的风险,以便选择最有利的治疗策略。
纳入2008年至2012年期间在Podlaskie省四个侵入性心脏病学中心住院的101例TTS患者。患者分为两组:I组52例(GRACE≤140分)和II组49例(GRACE>140分)。
研究组的平均GRACE评分为138.66。GRACE评分较高的患者中,应激性心肌病患者的住院时间与肺炎发生率较高(36.7%对7.69%,P=0.0004)、心律失常(17.3%对3.85%,P=0.026)以及严重并发症(心源性休克、肺水肿和心脏骤停)(30.6%对5.77%,P=0.001)相关。平均观察期为7.2年。GRACE评分≥140的患者组中,6个月(18.37%对3.85%,P=0.019)、1年(22.45对3.85%,P=0.005)、3年(40.82对3.85%,P<0.0001)、5年(42.86%对3.85%,P<0.0001)和7年死亡率(53.06%对9.62%,P<0.0001)的风险显著更高。在包括低体重指数、低估算肾小球滤过率和较高GRACE评分的多因素分析中,所有这些因素都是死亡的独立预测因素(P=0.042;P=0.010;P=0.041)。ROC曲线显示了GRACE评分对随访预后的鉴别分数。GRACE评分的ROC曲线下面积(AUC)为0.805(95%CI:0.718-0.892,P<0.0001),截断值为153分,应激性心肌病的敏感性为74%,特异性为77%。
GRACE评分对TTS患者早期和长期观察中的死亡风险预后具有很高的价值。